Immune Pharmaceuticals CEO to Chair Biotechnology Industry Organization (BIO) International Panel "Can Israel Become the Next Biotech Startup Nation?"
4/23/2013 9:36:11 AM
More...
|
Immune Pharmaceuticals Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
2/21/2013 8:59:16 AM
More...
|
Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
1/10/2013 6:21:54 AM
More...
|
Immune Pharmaceuticals and EpiCept Corporation (EPCT) Agree to Merge
11/8/2012 9:44:56 AM
More...
|
Immune Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute
5/23/2012 10:24:21 AM
More...
|
Immune Pharmaceuticals Granted US$1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel
1/30/2012 9:22:35 AM
More...
|
Isaac Kobrin, M.D. Joins Immune Pharmaceuticals' Board of Directors
11/29/2011 12:39:33 PM
More...
|
Immune Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
9/13/2011 11:30:38 AM
More...
|
iCo Therapeutics Inc. Executes Bertilimumab License with Immune Pharmaceuticals in Deal Worth $32 Million
6/24/2011 1:05:15 PM
More...
|